VeriMomgarcinia hanburyi sap powder est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
Related ingredients
Frequently asked questions
- garcinia hanburyi sap powder est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
- garcinia hanburyi sap powder est-il sûr pendant l'allaitement ?
- No specific data indicating reproductive or lactation-related toxicity or harmonised classification. Potential for low dermal absorption of small bioactive constituents suggests low but measurable maternal exposure and theoretical transfer into milk cannot be excluded, so exposure scored 1. No direct evidence of breastmilk transfer or infant effects in prioritized sources (ECHA Annex VI, CIR, PubMed, PubChem).
- garcinia hanburyi sap powder est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental data were found. Because the ingredient contains small lipophilic xanthonoids (e.g., gambogic acid) that could be dermally absorbed, infant exposure score is increased by +1 from adult exposure (adult e=1 → baby e=2) to reflect immature barrier and higher surface‑area‑to‑weight ratio. No data were found to justify increasing hazard or mechanism scores for infants.
- Comment VeriMom évalue-t-il garcinia hanburyi sap powder ?
- VeriMom évalue garcinia hanburyi sap powder à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à garcinia hanburyi sap powder pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à garcinia hanburyi sap powder basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.